Regulation of immune responses by neutrophils

Annals of the New York Academy of Sciences

Volumn 1319, Issue 1, 2014, Pages 66-81

  Wang, Jing ^a,b   Arase, Hisashi ^b,c,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Chronic diseases; Inflammation; Neutrophils; Recruitment

Indexed keywords

CD18 ANTIGEN; CD31 ANTIGEN; CD99 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; ELASTASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE B; JUNCTIONAL ADHESION MOLECULE C; LEUKOTRIENE B4; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOSTATIN M; OXIDIZED LOW DENSITY LIPOPROTEIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PENTRAXIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ARTICLE; ASTHMA; ATHEROSCLEROSIS; BACTERIAL INFECTION; BONE MARROW; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFORMATIONAL TRANSITION; CYSTIC FIBROSIS; CYTOTOXICITY; DISEASE COURSE; EMPHYSEMA; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; LEUKOCYTE ACTIVATION; MULTIPLE SCLEROSIS; NEOPLASM; NEUTROPHIL; NONHUMAN; PAPILLON LEFEVRE SYNDROME; PATTERN RECOGNITION; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SMOKING; STAPHYLOCOCCUS AUREUS; VASCULITIS; WEGENER GRANULOMATOSIS;

CHRONIC DISEASES; INFLAMMATION; NEUTROPHILS; RECRUITMENT;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; NEUTROPHIL INFILTRATION; NEUTROPHILS;

EID: 84902990206     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12445     Document Type: Article

References (178)

1. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6:173-182.
2. Amulic, B., C. Cazalet, G.L. Hayes, et al. 2012. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30:459-489.
3. Phillipson, M. & P. Kubes. 2011. The neutrophil in vascular inflammation. Nat. Med. 17:1381-1390.
4. Kreisel, D. et al. 2010. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc. Natl. Acad. Sci. U.S.A. 107:18073-18078.
5. Yipp, B.G. & P. Kubes. 2013. Antibodies against neutrophil LY6G do not inhibit leukocyte recruitment in mice in vivo. Blood 121:241-242.
6. Wang, J.X. et al. 2012. Ly6G ligation blocks recruitment of neutrophils via a beta2-integrin-dependent mechanism. Blood 120:1489-1498.
7. Seok, J. et al. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A. 110:3507-3512.
8. Mestas, J. & C.C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172:2731-2738.
9. Davey, M.S. et al. 2011. Failure to detect production of IL-10 by activated human neutrophils. Nat. Immunol. 12:1017-1018; author reply 1018-1020.
10. Appelberg, R. 2007. Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol. 15:87-92.
11. Lowe, D.M., P.S. Redford, R.J. Wilkinson, et al. 2012. Neutrophils in tuberculosis: friend or foe? Trends Immunol. 33:14-25.
12. Jenne, C.N. et al. 2013. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13:169-180.
13. Saitoh, T. et al. 2012. Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe 12:109-116.
14. Beyrau, M., J.V. Bodkin & S. Nourshargh. 2012. Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol. 2:120134.
15. Mantovani, A., M.A. Cassatella, C. Costantini & S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11:519-531.
16. Beauvillain, C. et al. 2011. CCR7 is involved in the migration of neutrophils to lymph nodes. Blood 117, 1196-1204.
17. Beauvillain, C. et al. 2007. Neutrophils efficiently cross-prime naive T cells in vivo. Blood 110:2965-2973.
18. Bennouna, S. & E.Y. Denkers. 2005. Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production. J. Immunol. 174:4845-4851.
19. Puga, I. et al. 2012. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13:170-180.
20. van Gisbergen, K.P., T.B. Geijtenbeek & Y. van Kooyk. 2005. Close encounters of neutrophils and DCs. Trends Immunol. 26, 626-631.
21. van Gisbergen, K.P., I.S. Ludwig, T.B. Geijtenbeek & Y. van Kooyk. 2005. Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils. FEBS Lett. 579:6159-6168.
22. van Gisbergen, K.P., M. Sanchez-Hernandez, T.B. Geijtenbeek & Y. van Kooyk. 2005. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J. Exp. Med. 201:1281-1292.
23. Jaillon, S. et al. 2013. Neutrophils in innate and adaptive immunity. Semin. Immunopathol. 35:377-394.
24. Mary, J.Y. 1985. Normal human granulopoiesis revisited. II. Bone marrow data. Biomed. Pharmacother. 39:66-77.
25. Borregaard, N. 2010. Neutrophils, from marrow to microbes. Immunity 33:657-670.
26. Nusse, O. & M. Lindau. 1988. The dynamics of exocytosis in human neutrophils. J. Cell Biol. 107:2117-2123.
27. Faurschou, M. & N. Borregaard. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5:1317-1327.
28. Borregaard, N., O.E. Sorensen & K. Theilgaard-Monch. 2007. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28:340-345.
29. Galli, S.J., N. Borregaard & T.A. Wynn. 2011. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12:1035-1044.
30. Summers, C. et al. 2010. Neutrophil kinetics in health and disease. Trends Immunol. 31:318-324.
31. Matsushima, H. et al. 2013. Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood 121:1677-1689.
32. Geng, S. et al. 2013. Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice. Blood 121:1690-1700.
33. Pillay, J. et al. 2010. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116:625-627.
34. Tofts, P.S., T. Chevassut, M. Cutajar, et al. 2011. Doubts concerning the recently reported human neutrophil lifespan of 5.4 days. Blood 117:6050-6052; author reply 6053-6054.
35. Li, K.W., S.M. Turner, C.L. Emson, et al. 2011. Deuterium and neutrophil kinetics. Blood 117:6052-6053; author reply 6053-6054.
36. Casanova-Acebes, M. et al. 2013. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 153:1025-1035.
37. Colotta, F., F. Re, N. Polentarutti, et al. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020.
38. Kim, M.H. et al. 2011. Neutrophil survival and c-kit(+)-progenitor proliferation in Staphylococcus aureus-infected skin wounds promote resolution. Blood 117:3343-3352.
39. Eash, K.J., A.M. Greenbaum, P.K. Gopalan & D.C. Link. 2010. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120:2423-2431.
40. Hernandez, P.A. et al. 2003. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 34:70-74.
41. Eash, K.J., J.M. Means, D.W. White & D.C. Link. 2009. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood 113:4711-4719.
42. Devi, S. et al. 2013. Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow. J. Exp. Med. 210:2321-2336.
43. Christopher, M.J., F. Liu, M.J. Hilton, et al. 2009. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 114:1331-1339.
44. Ley, K., C. Laudanna, M.I. Cybulsky & S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-689.
45. Schmidt, S., M. Moser & M. Sperandio. 2013. The molecular basis of leukocyte recruitment and its deficiencies. Mol. Immunol. 55:49-58.
46. Muller, W.A. 2013. Getting leukocytes to the site of inflammation. Vet. Pathol. 50:7-22.
47. Sundd, P., M.K. Pospieszalska & K. Ley. 2013. Neutrophil rolling at high shear: flattening, catch bond behavior, tethers and slings. Mol. Immunol. 55:59-69.
48. Sundd, P. et al. 2012. 'Slings' enable neutrophil rolling at high shear. Nature 488:399-403.
49. Yago, T. et al. 2010. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood 116:485-494.
50. Mueller, H. et al. 2010. Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways. Blood 115:3118-3127.
51. Campbell, J.J. et al. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279:381-384.
52. Constantin, G. et al. 2000. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759-769.
53. Yang, L. et al. 2005. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 106:584-592.
54. Ye, F., C. Kim & M.H. Ginsberg. 2012. Reconstruction of integrin activation. Blood 119:26-33.
55. Klein, C. 2011. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu. Rev. Immunol. 29:399-413.
56. Kempf, T. et al. 2011. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat. Med. 17:581-588.
57. Choi, E.Y. et al. 2008. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322:1101-1104.
58. Eskan, M.A. et al. 2012. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 13:465-473.
59. Wang, J., I. Shiratori, J. Uehori, et al. 2013. Neutrophil infiltration during inflammation is regulated by PILRalpha via modulation of integrin activation. Nat. Immunol. 14:34-40.
60. Deban, L. et al. 2010. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat. Immunol. 11:328-334.
61. Carman, C.V. & T.A. Springer. 2008. Trans-cellular migration: cell-cell contacts get intimate. Curr. Opin. Cell Biol. 20:533-540.
62. Schenkel, A.R., E.M. Dufour, T.W. Chew, et al. 2007. The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response. Cell Commun. Adhesion 14:227-237.
63. Lou, O., P. Alcaide, F.W. Luscinskas & W.A. Muller. 2007. CD99 is a key mediator of the transendothelial migration of neutrophils. J. Immunol. 178:1136-1143.
64. Muller, W.A., S.A. Weigl, X. Deng & D.M. Phillips. 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:449-460.
65. Burns, A.R. et al. 2000. Analysis of tight junctions during neutrophil transendothelial migration. J. Cell Sci. 113(Pt 1): 45-57.
66. Proebstl, D. et al. 2012. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J. Exp. Med. 209:1219-1234.
67. Stark, K. et al. 2013. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs. Nat. Immunol. 14:41-51.
68. Rossaint, J. & A. Zarbock. 2013. Tissue-specific neutrophil recruitment into the lung, liver, and kidney. J. Innate Immun. 5:348-357.
69. McDonald, B. & P. Kubes. 2012. Neutrophils and intravascular immunity in the liver during infection and sterile inflammation. Toxicol. Pathol. 40:157-165.
70. McDonald, B. et al. 2008. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med. 205:915-927.
71. Doerschuk, C.M. 2000. Leukocyte trafficking in alveoli and airway passages. Respiratory Res. 1:136-140.
72. Devi, S. et al. 2013. Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus. Nat. Med. 19:107-112.
73. Tang, T. et al. 1997. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 186:1853-1863.
74. Hayashi, F., T.K. Means & A.D. Luster. 2003. Toll-like receptors stimulate human neutrophil function. Blood 102:2660-2669.
75. Trinchieri, G. & Sher, A. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7:179-190.
76. Parker, L.C., M.K. Whyte, S.K. Dower & I. Sabroe. 2005. The expression and roles of toll-like receptors in the biology of the human neutrophil. J. Leukoc. Biol. 77:886-892.
77. Mayadas, T.N., X. Cullere & C.A. Lowell. 2013. The multifaceted functions of neutrophils. Ann. Rev. Pathol. 9:181-218.
78. Brinkmann, V. et al. 2004. Neutrophil extracellular traps kill bacteria. Science 303:1532-1535.
79. Papayannopoulos, V. & A. Zychlinsky. 2009. NETs: a new strategy for using old weapons. Trends Immunol. 30:513-521.
80. Fuchs, T.A. et al. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176:231-241.
81. Thammavongsa, V., D.M. Missiakas & O. Schneewind. 2013. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science 342:863-866.
82. Metzler, K.D. et al. 2011. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117:953-959.
83. Papayannopoulos, V., K.D. Metzler, A. Hakkim & A. Zychlinsky. 2010. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191:677-691.
84. Bianchi, M. et al. 2009. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114:2619-2622.
85. Parker, H., M. Dragunow, M.B. Hampton, et al. 2012. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J. Leukoc. Biol. 92:841-849.
86. Li, P. et al. 2010. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853-1862.
87. von Bruhl, M.L. et al. 2012. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209:819-835.
88. Yipp, B.G. et al. 2012. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18:1386-1393.
89. Caudrillier, A. et al. 2012. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Invest. 122:2661-2671.
90. Hakkim, A. et al. 2010. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U.S.A. 107:9813-9818.
91. Garcia-Romo, G.S. et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3:73ra20, doi:10.1126/scitranslmed.3001201.
92. Lande, R. et al. 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3:73ra19, doi:10.1126/scitranslmed.3001180.
93. Kessenbrock, K. et al. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15:623-625.
94. Clark, S.R. et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13:463-469.
95. Cools-Lartigue, J. et al. 2013. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. 123:3446-3458.
96. Chen, G.Y. & G. Nunez. 2010. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10:826-837.
97. McDonald, B. et al. 2010. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362-366.
98. Lammermann, T. et al. 2013. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498:371-375.
99. Christoffersson, G. et al. 2012. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 120:4653-4662.
100. Buckley, C.D., D.W. Gilroy, C.N. Serhan, et al. 2013. The resolution of inflammation. Nat. Rev. Immunol. 13:59-66.
101. Soehnlein, O. & L. Lindbom. 2010. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10:427-439.
102. Lauber, K. et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717-730.
103. Peter, C. et al. 2008. Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A. J. Biol. Chem. 283:5296-5305.
104. Elliott, M.R. et al. 2009. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282-286.
105. Witko-Sarsat, V. et al. 2010. Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival. J. Exp. Med. 207:2631-2645.
106. Thompson, A.A. et al. 2014. Hypoxia-inducible factor 2alpha regulates key neutrophil functions in humans, mice, and zebrafish. Blood 123:366-376.
107. Rossi, A.G. et al. 2006. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12:1056-1064.
108. Perretti, M. & F. D'Acquisto. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9:62-70.
109. Bournazou, I. et al. 2009. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J. Clin. Invest. 119:20-32.
110. Funk, C.D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875.
111. Serhan, C.N. 2007. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25:101-137.
112. Filep, J.G., C. Zouki, N.A. Petasis, et al. 1999. Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. Blood 94:4132-4142.
113. Jozsef, L., C. Zouki, N.A. Petasis, et al. 2002. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. U.S.A. 99:13266-13271.
114. Arita, M., C.B. Clish & C.N. Serhan. 2005. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem. Biophys. Res. Commun. 338:149-157.
115. Schwab, J.M., N. Chiang, M. Arita & C.N. Serhan. 2007. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869-874.
116. Ariel, A. et al. 2006. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat. Immunol. 7:1209-1216.
117. Oh, S.F., P.S. Pillai, A. Recchiuti, et al. 2011. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J. Clin. Invest. 121:569-581.
118. Kennedy, A.D. & F.R. DeLeo. 2009. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43:25-61.
119. Hecker, L. et al. 2009. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 15:1077-1081.
120. Snelgrove, R.J. et al. 2010. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 330:90-94.
121. Silman, A.J., M.C. Hochberg & C. Cooper. 2001. Epidemiology of the Rheumatic Diseases. 2nd edn. Oxford, UK: Oxford University Press.
122. Raza, K. et al. 2006. Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis. Arthritis Res. Ther. 8:R120.
123. Quayle, J.A., F. Watson, R.C. Bucknall & S.W. Edwards. 1997. Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression. Immunology 91:266-273.
124. Radstake, T.R. et al. 2006. The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis. Arthritis Rheum. 54:3828-3837.
125. Lunec, J., H.R. Griffiths & S. Brailsford. 1988. Oxygen free radicals denature human IgG and increase its reactivity with rheumatoid factor antibody. Scand. J. Rheumatol. Suppl. 75:140-147.
126. Griffiths, H.R., J. Lunec, C.A. Gee & R.L. Willson. 1988. Oxygen radical induced alterations in polyclonal IgG. FEBS Lett. 230:155-158.
127. Mohr, W., H. Westerhellweg & D. Wessinghage. 1981. Polymorphonuclear granulocytes in rheumatic tissue destruction. III. An electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis. Ann. Rheum. Dis. 40:396-399.
128. Wipke, B.T. & P.M. Allen. 2001. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167:1601-1608.
129. Monach, P.A. et al. 2010. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum. 62:753-764.
130. Chou, R.C. et al. 2010. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33:266-278.
131. Kim, N.D., R.C. Chou, E. Seung, et al. 2006. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J. Exp. Med. 203:829-835.
132. Jakus, Z., E. Simon, D. Frommhold, et al. 2009. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. J. Exp. Med. 206:577-593.
133. Lane, S.E., R. Watts & D.G. Scott. 2005. Epidemiology of systemic vasculitis. Curr. Rheumatol. Rep. 7:270-275.
134. Harper, L., P. Cockwell, D. Adu & C.O. Savage. 2001. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 59:1729-1738.
135. Brouwer, E. et al. 1994. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int. 45:1120-1131.
136. Kain, R. et al. 2008. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat. Med. 14:1088-1096.
137. Schreiber, A. et al. 2009. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J. Am. Soc. Nephrol. JASN 20:289-298.
138. Huugen, D. et al. 2007. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int. 71:646-654.
139. Mulder, A.H., C.A. Stegeman & C.G. Kallenberg. 1995. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin. Exp. Immunol. 101:227-232.
140. Saffarzadeh, M. et al. 2012. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PloS One 7:e32366.
141. Abdgawad, M. et al. 2010. Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression. Clin. Exp. Iimmunol. 161, 89-97.
142. Gregory, A.D. & A.M. Houghton. 2011. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 71:2411-2416.
143. Houghton, A.M. et al. 2010. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 16:219-223.
144. Sparmann, A. & D. Bar-Sagi. 2004. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6:447-458.
145. Queen, M.M., R.E. Ryan, R.G. Holzer, et al. 2005. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 65:8896-8904.
146. Rao, H.L. et al. 2012. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PloS One 7:e30806.
147. Jensen, H.K. et al. 2009. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27:4709-4717.
148. Li, Y.W. et al. 2011. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 54:497-505.
149. Fridlender, Z.G. et al. 2009. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16:183-194.
150. McGill, H.C., Jr., C.A. McMahan & S.S. Gidding. 2008. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 117:1216-1227.
151. Rotzius, P. et al. 2010. Distinct infiltration of neutrophils in lesion shoulders in ApoE-/- mice. Am. J. Pathol. 177:493-500.
152. Zernecke, A. et al. 2008. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 102:209-217.
153. Naruko, T. et al. 2002. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106:2894-2900.
154. Ionita, M.G. et al. 2010. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler. Thromb. Vasc. Biol. 30:1842-1848.
155. Weber, C., A. Zernecke & P. Libby. 2008. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8:802-815.
156. Drechsler, M., R.T. Megens, M. van Zandvoort, et al. 2010. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122:1837-1845.
157. Doring, Y. et al. 2012. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ. Res. 110:1052-1056.
158. Braunersreuther, V. et al. 2007. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscl. Thromb. Vasc. Biol. 27, 373-379.
159. Huo, Y. et al. 2003. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9:61-67.
160. Massberg, S. et al. 2002. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196:887-896.
161. von Hundelshausen, P. & C. Weber. 2007. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100:27-40.
162. Johnson, R.C. et al. 1997. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99:1037-1043.
163. Nageh, M.F. et al. 1997. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscl. Thromb. Vasc. Biol. 17:1517-1520.
164. Collins, R.G. et al. 2000. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med. 191:189-194.
165. Li, W. et al. 2012. Intravital 2-photon imaging of leukocyte trafficking in beating heart. J. Clin. Invest. 122:2499-2508.
166. Pham, C.T., J.L. Ivanovich, S.Z. Raptis, et al. 2004. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J. Immunol. 173:7277-7281.
167. Horwitz, M.S. et al. 2007. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 109:1817-1824.
168. Henriksen, P.A. & J.M. Sallenave. 2008. Human neutrophil elastase: mediator and therapeutic target in atherosclerosis. Int. J. Biochem. Cell Biol. 40:1095-1100.
169. Kelly, E., C.M. Greene & N.G. McElvaney. 2008. Targeting neutrophil elastase in cystic fibrosis. Expert Opin. Ther. Targets 12:145-157.
170. Sibelius, U. et al. 1998. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response. J. Exp. Med. 187:497-503.
171. Van Der Geld, Y.M. et al. 2001. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Kidney Int. 59:147-159.
172. Merched, A., K. Tollefson & L. Chan. 2010. Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice. Cardiovasc. Res. 85:853-863.
173. Watts, R. et al. 2005. Translational research in autoimmunity: aims of therapy in vasculitis. Rheumatology 44:573-576.
174. Muroski, M.E. et al. 2008. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr. Pharm. Biotechnol. 9:34-46.
175. Simpson, J.L., H. Powell, M.J. Boyle, et al. 2008. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am. J. Respir. Crit. Care Med. 177:148-155.
176. Dubois, B., G. Opdenakker & H. Carton. 1999. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neurol. Belgica 99, 53-56.
177. Wong, C.M., G. Bansal, L. Pavlickova, et al. 2013. Reactive oxygen species and antioxidants in pulmonary hypertension. Antioxidants Redox Signal. 18:1789-1796.
178. Soehnlein, O. 2012. Multiple roles for neutrophils in atherosclerosis. Circ. Res. 110:875-888.